Frederick W. Driscoll's most recent trade in Cellectar Biosciences Inc was a trade of 60,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cue Biopharma Inc | Frederick W. Driscoll | Director | 02 Jan 2025 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | ||
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cue Biopharma Inc | Frederick W. Driscoll | Director | 02 Jan 2024 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | ||
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 47,650 | - | - | Stock option (right to buy) | |
| Cue Biopharma Inc | Frederick W. Driscoll | Director | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| MEI Pharma Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) | |
| Cue Biopharma Inc | Frederick W. Driscoll | Director | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 03 Sep 2021 | 19,417 | 19,417 (0%) | 0% | 1.0 | 20,244 | Common Stock |
| MEI Pharma Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 78,000 | 78,000 | - | - | Stock option (right to buy) | |
| MEI Pharma Inc | Frederick W. Driscoll | Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 23 Feb 2021 | 25,000 | 37,500 (0%) | 0% | 4.0 | 100,625 | Common Stock |
| Cue Biopharma Inc | Frederick W. Driscoll | Director | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |